Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

Recent & Breaking News (OTCQX:MRVFF)

Nuvo Pharmaceuticals(TM) Update to Nuvo's Presentation Time at H.C. Wainwright Global Investment Conference

PR Newswire September 9, 2019

Nuvo Pharmaceuticals™ Update to Nuvo's Presentation Time at H.C. Wainwright Global Investment Conference

Canada NewsWire September 9, 2019

Nuvo Pharmaceuticals(TM) to Present at H.C. Wainwright Global Investment Conference

PR Newswire September 4, 2019

Nuvo Pharmaceuticals™ to Present at H.C. Wainwright Global Investment Conference

Canada NewsWire September 4, 2019

Nuvo Pharmaceuticals(TM) Announces 2019 Second Quarter Results

PR Newswire August 14, 2019

Nuvo Pharmaceuticals(TM) Announces Second Quarter 2019 Results Release Date and Conference Call Details

Canada NewsWire July 31, 2019

Nuvo Pharmaceuticals(TM) Provides VIMOVO Patent Update

Canada NewsWire July 30, 2019

Nuvo Pharmaceuticals(TM) Announces Director Election Results of its Annual General Meeting and Updates to the Facility Agreement with Deerfield

Canada NewsWire June 26, 2019

Nuvo Pharmaceuticals(TM) Provides Corporate Update

Canada NewsWire June 17, 2019

IIROC Trade Resumption - NRI

Canada NewsWire May 15, 2019

Nuvo Pharmaceuticals(TM) Announces that U.S. Court of Appeals for the Federal Circuit Reverses District Court's Decision Related to Certain Vimovo Patents

Canada NewsWire May 15, 2019

IIROC Trading Halt - NRI

Canada NewsWire May 15, 2019

Nuvo Pharmaceuticals(TM) Announces 2019 First Quarter Results

Canada NewsWire May 14, 2019

Nuvo Pharmaceuticals(TM) to Present at the Bloom Burton & Co. Healthcare Investor Conference

Canada NewsWire April 23, 2019

Nuvo Pharmaceuticals™ Announces Pennsaid 2% Marketing Authorization Application Accepted for Review by AGES, the Austrian Agency for Health and Food Safety

Canada NewsWire April 2, 2019

Nuvo Pharmaceuticals™ Announces 2018 Fourth Quarter and Year-End Results

Canada NewsWire March 29, 2019

Nuvo Pharmaceuticals™ Announces the Filing of the Business Acquisition Report Related to the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets

Canada NewsWire March 15, 2019

Nuvo Pharmaceuticals™ Announces Receipt of Shareholder Approval By Way of Written Consent For the Issuance of Common Shares Pursuant to Convertible Notes and Warrants

Canada NewsWire March 11, 2019

Nuvo Pharmaceuticals™ Announces Appointment of Rob Harris as Executive Chairman

Canada NewsWire January 3, 2019

Nuvo Pharmaceuticals™ to Host Conference Call/Audio Webcast to Discuss the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets

Canada NewsWire January 2, 2019